Literature DB >> 25653042

Local and systemic proteolytic responses in chronic rhinosinusitis with nasal polyposis and asthma.

Elina Katainen1, Katriina Kostamo, Paula Virkkula, Timo Sorsa, Taina Tervahartiala, Aaro Haapaniemi, Elina Toskala.   

Abstract

BACKGROUND: Chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma coexist frequently and share similar features of inflammation and remodeling. Remodeling has become an important concept in the pathophysiology of asthma and CRSwNP. It happens early in the development of these diseases and is relatively resistant to treatments. The key enzymes responsible for remodeling are matrix metalloproteinases (MMPs). In this study we examined whether asthma and CRSwNP share similar MMP profiles.
METHODS: Nasal secretion and serum specimens of controls (19 subjects) and patients with asthma (12), CRSwNP (39), or both (16) were collected between December 2007 and May 2009. Groups were divided into 2 subgroups according to atopy. MMP-7, MMP-9, MMP-13, tissue inhibitors of metalloproteinases (TIMPs), TIMP-1 and TIMP-2, myeloperoxidase (MPO), and human neutrophil elastase (HNE) were measured using enzyme-linked immunosorbent assay (ELISA), and MMP-8 was determined using immunofluorometric assay. High-sensitivity C-reactive protein (hs-CRP) was measured to estimate systemic involvement.
RESULTS: Patients with asthma, CRSwNP, or both exhibited lower MMP-9, MMP-9/TIMP-1, MMP-9/TIMP-2, and MPO in nasal secretions (p < 0.05 in CRSwNP) and higher MMP-9, MMP-9/TIMP-1, MMP-9/TIMP-2, and HNE in serum (p < 0.05 in all groups) compared to controls, whereas no difference in MMP-7, MMP-13, TIMP-1, and TIMP-2 were detected. Atopy increased nasal MMP-9 and MPO expression. hs-CRP was higher in patients with CRSwNP and asthma compared to controls.
CONCLUSION: Our findings suggest shared pathomechanisms behind asthma and CRSwNP. Contrasting local vs systemic results reflect a different ability of healthy mucosa to react to exogenous stimuli, possibly indicating a protective function of MMP-9 and possibly also MMP-8 in the airways.
© 2015 ARS-AAOA, LLC.

Entities:  

Keywords:  asthma; atopy; chronic rhinosinusitis; metalloproteinases; nasal polyps

Mesh:

Substances:

Year:  2015        PMID: 25653042     DOI: 10.1002/alr.21486

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  6 in total

1.  Study on the effects of desloratadine citrate disodium on the postoperative complications and inflammatory response in patients with chronic sinusitis undergoing endoscopic sinus surgery.

Authors:  Ming Ma; Longsheng Liu; Wei Jin; Hong Chen; Tao Zhou; Busheng Tong
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  [Peripheral blood cell count and inflammation-based markers in chronic rhinosinusitis].

Authors:  O Zagólski; P Stręk; W Jurczak; P Gorzedowski
Journal:  HNO       Date:  2018-08       Impact factor: 1.284

3.  Expression of MMP-9/TIMP-2 in nasal polyps and its functional implications.

Authors:  Xuechang Li; Yanli Tao; Xuezhong Li
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Different effects of allergic rhinitis on nasal mucosa remodeling in chronic rhinosinusitis with and without nasal polyps.

Authors:  Rong Xiang; Qing-Ping Zhang; Wei Zhang; Yong-Gang Kong; Lu Tan; Shi-Ming Chen; Yu-Qin Deng; Ze-Zhang Tao; Yu Xu
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-11-16       Impact factor: 2.503

5.  Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps?

Authors:  Antonella Vetuschi; Simona Pompili; Gian Piero Di Marco; Federico Calvaruso; Enzo Iacomino; Lidia Angelosante; Claudio Festuccia; Alessandro Colapietro; Roberta Sferra
Journal:  Eur J Histochem       Date:  2020-01-23       Impact factor: 3.188

Review 6.  Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran.

Authors:  Khalil Ansarin; Davood Attaran; Hamidreza Jamaati; Mohammad Reza Masjedi; Hamidreza Abtahi; Ali Alavi; Masoud Aliyali; Amir Mohammad Hashem Asnaashari; Reza Farid-Hosseini; Seyyed Mohammad Ali Ghayumi; Hassan Ghobadi; Atabak Ghotb; Abolhassan Halvani; Abbas Nemati; Mohammad Hossein Rahimi Rad; Masoud Rahimian; Ramin Sami; Hamid Sohrabpour; Sasan Tavana; Mohammad Torabi-Nami; Parviz Vahedi
Journal:  Tanaffos       Date:  2015
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.